This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: T31.3 (Burns involving 30-39% of body surface) | Special Copayment Reduction: V248 (Severe burn special copayment reduction, item 2: condition of 30% or more of body surface area or including third-degree burns; 5% copayment for 1 year from the registration date) |
| B. Synonyms | Severe burn, extensive full-thickness burn, extensive full-thickness burn, 30–39% TBSA burn, major burn (30–39% BSA) |
| C. Adult onset | In adults, full-thickness (third-degree) burns of 30–39% of body surface area are life-threatening injuries requiring immediate transfer to a specialized burn center and intensive care, and without appropriate treatment they can lead to death from burn shock, multiple organ failure, and sepsis. |
| 1. History | Traces the lineage of modern burn medicine from ancient papyri to the development of the Parkland formula after World War II. |
| 2. Causes | Covers the main causes, including flame burns, explosion burns, hot liquid and steam burns, electrical burns, and chemical burns, as well as occupational and environmental risk factors. |
| 3. Genetics | Burns themselves are not genetic diseases, but polymorphisms of inflammatory response genes (TNF-α, IL-6, TLR4) affect susceptibility to sepsis and prognosis. |
| 4. General epidemiology | About 180,000 burn deaths worldwide each year; among annual burn inpatients in Korea, 30% TBSA or more serves as the criterion for severe classification. |
| 5. Pathophysiology | Describes in detail the pathophysiology of full-thickness skin destruction by heat, massive fluid loss, systemic inflammatory response syndrome (SIRS), and burn shock. |
| 6. Symptoms | Explains the painlessness of third-degree burns, leathery eschar, symptoms of shock, and dyspnea with associated inhalation injury. |
| 7. Signs | Describes physical signs such as hard, leathery eschar, pale, brown, or black lesions, loss of capillary refill, hypotension, tachycardia, and hypothermia. |
| 8. Screening | Explains TBSA calculation using the Rule of Nines and the Lund-Browder chart, the palm method, and burn depth classification methods. |
| 9. Diagnosis | Includes clinical diagnostic criteria, laboratory findings (ABG, CBC, BMP, lactate), imaging, bronchoscopy, and inhalation injury assessment. |
| 10. Treatment | Systematically describes Parkland formula fluid resuscitation, early excision and skin grafting, ICU management, nutritional support, and infection prevention and treatment. |
| 11. Prognosis | Discusses the revised Baux score, mortality by age, TBSA, and inhalation injury, long-term complications, and rehabilitation outlook. |
| 12. Prevention | Explains public health approaches such as installing fire detectors, using flame-retardant materials, occupational safety education, and burn prevention programs. |
| 13. References | Baxter CR. Fluid volume and electrolyte changes in the early post-burn period. Clin Plast Surg. 1974 … and 9 other papers |
The history of burn treatment began with human civilization. The ancient Egyptian Ebers Papyrus of around 1550 BC records a treatment in which a mixture of frog hair and soot was applied to burn wounds, and in the Greek and Roman period, methods of applying honey, olive oil, wine, and the like to wounds were used. Although these ancient empirical treatments lacked scientific evidence, they had some validity in terms of moisture retention and antibacterial effects.
The turning point of modern burn medicine was World War II. As the number of patients with large-scale flame injuries surged during the war, the importance of fluid resuscitation came to the fore, and the 1942 Cocoanut Grove nightclub fire in Boston (492 deaths) became the direct impetus for the establishment of modern burn centers. After this event, Cope and Moore (1947) were the first to systematically describe the mechanisms of plasma loss and edema formation in burn patients.
In the 1960s, Charles Baxter and Tom Shires developed the optimal formula for fluid resuscitation using Lactated Ringer's solution through large-scale clinical studies at Parkland Memorial Hospital in Dallas. The so-called Parkland formula (4 mL/kg/TBSA%), published in 1968, became the standard of burn care worldwide for more than half a century thereafter. This formula calculates the total volume of crystalloid needed during the first 24 hours, with half given in the first 8 hours and the remaining half over the next 16 hours.
After the 1970s, the concept of early excision and grafting was introduced and dramatically reduced mortality. Burke, Bondoc, and Quinby (1974) showed that in patients with severe burns of 30% or more of body surface area, excising necrotic tissue and performing skin grafting within 5 days of injury greatly increases survival compared with delayed treatment. In addition, the cultured epithelial autograft (CEA) technique developed by Howard Green and James Rheinwald in 1981 provided a breakthrough alternative when donor skin is insufficient in patients with large-area burns.
In the 1980s–1990s, along with the establishment of specialized burn centers in Korea and abroad, advances in critical care medicine, infection control, and nutritional support contributed to reducing burn mortality. Since its founding in 1988, the Korean Burn Society has contributed greatly to standardizing burn treatment in Korea and establishing the special copayment reduction program, and the severe burn special copayment reduction (V248) registration program eases the burden on patients from high treatment costs, ensuring access to appropriate treatment.
In the 21st century, bioengineered skin substitutes, negative pressure wound therapy, extracorporeal membrane oxygenation (ECMO), and immunomodulatory therapy have been introduced, and the prognosis of patients with severe burns of 30–39% of body surface area continues to improve. Systematic prognosis prediction using the revised Baux score (revised Baux score = age + TBSA + 17 × inhalation injury) and intensive treatment in specialized burn intensive care units form the core of modern burn medicine.
Full-thickness (third-degree) burns involving 30–39% of body surface area usually occur with exposure to an intense and sustained heat source or simultaneous exposure of extensive body regions. By cause, flame burns are the most common, accounting for about 40–50% of all severe burns. Gas explosions, fires, and accidents while handling flammable substances are typical, and when clothing catches fire and several body regions are injured simultaneously, extensive TBSA easily results.
In blast burns, flames and the explosive shock wave act together to cause deep injury over a wide area in an instant. Gas explosions, gunpowder explosions, and industrial accidents are common causes, and the rate of associated inhalation injury is high. Scald burns are caused by hot liquids or steam and can involve extensive areas, mainly in older adults and children. Steam in particular has a very high heat of vaporization and causes full-thickness injury even with short contact times.
Electrical burns occur when current passing through the body heats internal tissues, and even if the external burn area is small, internal deep tissue injury can be extensive, creating a risk of underestimating TBSA. Myoglobinuria and renal failure due to muscle necrosis are major complications. Chemical burns are caused by strong acids (sulfuric, hydrochloric, nitric acid) or strong alkalis (sodium hydroxide, potassium hydroxide), and alkali burns cause liquefactive necrosis and often produce deeper and more extensive injury than acid burns.
Occupational risk groups include firefighters, welders, workers at oil, gas, and chemical plants, and food service workers. Environmental factors that form the main background of extensive burns include house fires (particularly at night and under the influence of alcohol), wildfires, and war and armed conflict. Underlying conditions such as alcoholism, epilepsy, mental illness, and age-related mobility impairment are independent risk factors that increase the risk of burns and the extent of injury.
Burns themselves are not genetic diseases and do not arise from a direct genetic predisposition. However, the systemic response after burns—particularly the intensity of systemic inflammatory response syndrome (SIRS), susceptibility to sepsis, and the rate of wound healing—is regulated to a considerable extent by the individual's genetic background. Large-scale genomic studies have shown that the following gene polymorphisms are significantly associated with prognosis in burn patients.
TNF-α gene polymorphism (-308G/A): TNF-α is a key cytokine of the early inflammatory response after burns, and studies have reported that patients carrying the -308A allele are associated with an excessive inflammatory response, a higher incidence of sepsis, and increased mortality. Promoter polymorphisms of interleukin-6 (IL-6) and interleukin-10 (IL-10) are also known to affect the intensity of the post-burn cytokine storm and the development of multiple organ dysfunction syndrome (MODS).
The Toll-like receptor 4 (TLR4) polymorphism (Asp299Gly) can weaken the immune response to Gram-negative endotoxin, increasing the risk of sepsis in burn patients. Coagulation-related genes (Factor V Leiden, prothrombin G20210A variant) increase the risk of deep vein thrombosis in burn patients. Among wound healing-related genes, polymorphisms of the TGF-β1, VEGF, and MMP genes have been reported to be associated with the tendency to form hypertrophic scars and keloids. In severe burns in the 30–39% body surface area range, such genetic vulnerabilities can make meaningful differences in the clinical course and prognosis of individual patients.
According to the World Health Organization (WHO), burns cause about 180,000 deaths worldwide each year, more than 90% of which occur in low- and middle-income countries. The global disease burden of burns (DALY) reaches millions of days annually, and long-term complications and disabilities from nonfatal burns also cause enormous consumption of medical resources and socioeconomic losses.
According to the National Burn Database (NBIR) reports of the American Burn Association (ABA), about 486,000 burns present to medical facilities in the United States each year, of which about 40,000 require hospitalization. Severe burns of 30% or more of body surface area account for 5–10% of all burn admissions but more than 50% of burn-related deaths. By sex, the incidence in men is about twice that in women, and the proportion of work-related burns is particularly high among men in their 20s–40s.
In Korea, according to data from the Health Insurance Review & Assessment Service (HIRA), about 15,000–20,000 patients are hospitalized for burns each year, of whom several hundred a year register for special copayment reduction V248 for severe burns (30% or more of body surface area or including third-degree burns). The three major risk factors for burn death are older age (60 and over), 40% or more of body surface area, and inhalation injury, and studies indicate that mortality reaches 90% when all three factors are present.
Mortality in patients with burns of 30–39% of body surface area is about 10–25% when treated in a specialized burn center, but it varies greatly with the patient's age and the presence of inhalation injury. In young adults (in their 20s–30s), mortality for 30–39% TBSA burns without inhalation injury is below 5%, but in older patients aged 60 and over, mortality for burns of the same area can reach 30–50%.
The pathophysiology of full-thickness burns involving 30–39% of body surface area consists of three main axes: thermal tissue damage, the systemic vascular response, and disruption of the immune system. First, in terms of thermal injury, sustained exposure to a heat source of 60 degrees Celsius or higher causes coagulative necrosis of the full thickness of the skin, including the epidermis, dermis, and subcutaneous fat layer. In third-degree burns, the dermal nerve endings, hair follicles, and sweat glands are all destroyed, so pain sensation is lost and a pale or brown-to-black leathery eschar forms.
Within hours after the burn, various inflammatory mediators released from the locally injured area—histamine, bradykinin, prostaglandins, thromboxane, reactive oxygen species, and others—sharply increase vascular permeability. As a result, plasma proteins and water leak out of the vessels in large amounts, causing burn shock. In burns of 30% or more of body surface area, this response does not remain local but spreads to the systemic vasculature, causing generalized edema.
The decrease in plasma volume leads to reduced cardiac output, tissue hypoperfusion, and cellular hypoxia, and if left untreated it progresses to multiple organ dysfunction syndrome (MODS). At the same time, destruction of the skin barrier by thermal injury increases evaporative water loss to 10–15 times normal, raising the risk of hypothermia. Several days after the burn, a hypermetabolic state develops in which catabolism continues with a basal metabolic rate reaching twice normal, leading to muscle wasting, impaired immune function, and delayed wound healing.
The pathophysiologic zones of burn injury are explained by Jackson's three-zone model. The innermost zone of coagulation is irreversibly necrotic tissue; the surrounding zone of stasis is potentially salvageable tissue with impaired blood flow, and preserving this zone is at the core of treatment goals. The outermost zone of hyperemia has minor injury and can recover spontaneously. Therapeutic interventions such as fluid resuscitation, infection prevention, and prevention of hypothermia are aimed at preventing progression of necrosis in the zone of stasis.
Patients with full-thickness burns of 30–39% of body surface area present with very diverse and complex symptoms. Paradoxically, the third-degree burn areas themselves are painless or have markedly reduced pain, because the dermal nerve endings have been completely destroyed by heat. Instead, severe pain and a burning sensation appear in the second-degree burn areas at the periphery of the burn. It must always be kept in mind that the absence of pain complaints does not mean the injury is minor.
Systemic symptoms include hypotension, tachycardia, oliguria, and altered consciousness due to burn shock in the early phase. Severe thirst and nausea and vomiting due to extensive plasma loss are common, and ileus may accompany them. When inhalation injury is present, tracheal mucosal injury from smoke, carbon monoxide poisoning (headache, nausea, clouded consciousness, cherry-red skin), or sudden loss of consciousness due to hydrogen cyanide (HCN) poisoning can occur. Inhalation injury causes airway obstruction due to upper airway edema, bronchospasm, chemical pneumonitis, and so on.
As days pass after the burn, symptoms of the hypermetabolic syndrome come to the fore. Fever (high fever of 38–39°C or above suggests sepsis), chills, decreased appetite, and rapid weight loss persist. The burn wound shows abundant exudation initially, and later, at the eschar separation stage, signs of infection such as changes in the character of wound exudate, foul odor, and surrounding erythema may appear. In the long term, contracture from scar formation, functional impairment, and psychosocial problems (post-traumatic stress disorder, depression) become the main challenges of rehabilitation.
Physical signs observed in patients with full-thickness burns of 30–39% of body surface area are broadly divided into local signs of the burn wound and signs of the systemic response. As local wound signs, a pale or hard, leathery eschar is characteristically observed in third-degree burn areas. The eschar is pale white (waxy white), brown, or black and charred (charring), and capillary refill is absent when pressed by hand. Insensibility is confirmed by the inability to feel pain or touch even when pricked with a needle or rubbed with cotton.
When circumferential burns are present, the limbs may show loss of pulses, cyanosis, and signs of compartment syndrome. Circumferential chest burns restrict thoracic expansion and cause respiratory failure. As systemic signs, hypotension (systolic blood pressure below 90 mmHg), tachycardia (pulse >120/min), tachypnea (>25/min), hypothermia (body temperature <36°C), and oliguria (urine output <0.5 mL/kg/hr) are typical signs of burn shock.
When inhalation injury is present, hoarseness due to upper airway edema, inspiratory stridor, soot deposits on the face, neck, and oral mucosa, singed nasal hair, loss of eyebrows and eyelashes, and carbonaceous sputum on coughing are observed. In carbon monoxide poisoning, the skin may be cherry-red, but this is an unreliable sign. On laboratory values, hemoglobin appears high initially due to hemoconcentration and then decreases after hemolysis and fluid therapy, and hyponatremia, metabolic acidosis, and elevated blood creatinine may accompany it.
The most important screening test in the initial assessment of burn patients is TBSA (Total Body Surface Area) calculation. The two main methods for this are the Rule of Nines, which can be applied quickly in adults, and the more accurate Lund-Browder chart.
In the Rule of Nines, the head and neck are assigned 9%, each upper limb 9% (18% for both), the anterior chest 18%, the back 18%, each lower limb 18% (36% for both), and the perineum 1%, for a total of 100%. This method allows rapid assessment in emergencies but has large errors in children and obese patients. The Lund-Browder chart calculates TBSA more accurately by reflecting age-related changes in the area proportions of body regions and is recommended as the standard for formal burn assessment. In particular, it systematically reflects that in children the proportion of the head is higher and that of the lower limbs is lower.
An adjunctive method is the palmar surface method. Because the patient's palm (including the fingers) corresponds to about 1% of body surface area, it is useful for roughly estimating irregularly distributed burn areas. Burn depth classification should be done together with TBSA calculation, divided into first degree (superficial), superficial second degree, deep second degree, third degree (full thickness), and fourth degree (including muscle and bone). First-degree burns are not included in the TBSA calculation. When clinical assessment cannot distinguish depth, laser Doppler imaging or near-infrared spectroscopy is used as an adjunct.
Diagnosis of full-thickness burns of 30–39% of body surface area is based mainly on clinical criteria, and the following tests are essential for initial assessment and monitoring. Clinical diagnosis is made by integrating the extent of the burn (TBSA), depth (first- to fourth-degree classification), location (involvement of the face, airway, hands, perineum), cause (thermal, electrical, chemical, etc.), age, and associated injuries and diseases.
Laboratory tests needed include arterial blood gas analysis (ABG: PaO₂, PaCO₂, pH, HCO₃, carboxyhemoglobin), complete blood count (CBC), basic metabolic panel (BMP: electrolytes, renal function, blood glucose), blood lactate, coagulation tests (PT/aPTT, fibrinogen, D-dimer), liver function tests, blood CPK (when an electrical burn is suspected), urinalysis, and checking for myoglobinuria. When inhalation injury is suspected, measurement of carboxyhemoglobin (COHb) and methemoglobin (MetHb) is important.
For imaging, chest X-ray is basic, and chest CT is performed when inhalation injury or pneumonia is suspected. Bronchoscopy is the standard diagnostic method for airway inhalation injury, allowing direct confirmation of the degree of carbonization, edema, necrosis, and inflammation of the tracheal mucosa. Diagnostic criteria for thoracic inhalation injury include history (fire in an enclosed space), facial burns, singed nasal hair, soot deposits, and bronchoscopic findings. In electrical burns, ECG monitoring is essential. Hourly urine output (target 0.5–1 mL/kg/hr), central venous pressure, arterial blood gases, body temperature, and vital signs are used as indicators for continuous clinical monitoring.
Treatment of full-thickness burns of 30–39% of body surface area proceeds systematically in stages, from initial emergency treatment through intensive critical care, surgical wound treatment, and rehabilitation.
Following the ABCDE principle, the Airway is assessed immediately, and early intubation is recommended when inhalation injury or facial or neck burns are present. As edema progresses, intubation can become extremely difficult. Carbon monoxide poisoning is treated with 100% high-concentration oxygen. If hypoxemia persists, mechanical ventilation is applied.
Parkland formula: 4 mL × body weight (kg) × TBSA (%) of lactated Ringer's solution is given over the first 24 hours. For example, for a patient weighing 70 kg with 35% TBSA, 4 × 70 × 35 = 9,800 mL is given, with half (4,900 mL) in the first 8 hours and the remaining half over the next 16 hours. The infusion rate is continuously titrated to maintain hourly urine output at 0.5–1 mL/kg/hr. For 30% or more of body surface area, additional administration of colloid (especially albumin) is considered after the first 6 hours.
Preventing fluid creep: The Parkland formula should be understood as a starting point, not a maximum dose. Excessive fluid administration increases the risk of abdominal compartment syndrome, ARDS, pulmonary edema, and limb compartment syndrome. Therefore, titration should aim for the minimum effective volume while monitoring urine output, pulmonary artery wedge pressure, bladder pressure, and abdominal compartment pressure.
The current standard treatment is early excision and grafting: removing necrotic tissue by tangential excision or fascial excision as soon as possible after the burn (usually within 24–72 hours, at the latest within 5 days), followed by split-thickness autologous skin grafting (split-thickness skin graft, STSG). When donor sites are insufficient, temporary substitutes (xenograft skin, synthetic dermal substitutes, allograft skin) are used or mesh grafts (ratio up to 1:4) are employed. Negative pressure wound therapy (NPWT) is effective for graft fixation and improving graft take. When circumferential full-thickness burns are present, escharotomy is performed immediately to restore limb blood flow and chest motion.
Systemic prophylactic antibiotics are not recommended; the principle is targeted therapy based on wound surveillance cultures and clinical signs. Topical antimicrobials used include silver sulfadiazine, silver-containing dressings (Mepilex Ag, Aquacel Ag), and mupirocin. When sepsis is suspected, broad-spectrum antibiotics (including antipseudomonal activity, e.g., piperacillin/tazobactam, meropenem) are given promptly after cultures are taken.
Early enteral nutrition within 4–6 hours after the burn is recommended. The caloric target is determined by the Curreri formula or indirect calorimetry, and 1.5–2.5 g/kg/day of protein is needed. Supplementation with glutamine, vitamin C (antioxidant), and trace elements such as zinc and selenium is recommended.
To prevent hypothermia, the ambient temperature is maintained at 30–32°C, and warming blankets and radiant heat lamps are used. Prophylactic heparin for prevention of deep vein thrombosis (DVT), stress ulcer prophylaxis (proton pump inhibitors), pain and anxiety management (opioid, ketamine, dexmedetomidine), and early rehabilitation including physical and occupational therapy are provided in combination.
The prognosis of patients with full-thickness burns of 30–39% of body surface area differs markedly with the patient's age, presence of inhalation injury, comorbidities, and the level of the treating institution. The revised Baux score is calculated as age + TBSA (%) + 17 (if inhalation injury is present); 100 or less suggests a high likelihood of survival, and 140 or more suggests a poor prognosis. In a 30–39% TBSA burn, a 40-year-old patient without inhalation injury has a revised Baux score of 70–79, which is relatively favorable, but a 70-year-old patient with inhalation injury has a score of 117–126, with markedly higher mortality.
Mortality in specialized burn centers is about 10–25% for all 30–39% TBSA burns. However, in older adults aged 60 and over, mortality rises to 30–50% even for the same burn area, and an additional increase in mortality of about 15–20% has been reported with inhalation injury. In survivors, the average hospital stay reaches 30–60 days, and multiple operations are needed.
Long-term complications include hypertrophic scars, joint contractures, muscle wasting, chronic pain, pruritus, impaired thermoregulation (anhidrosis), psychological trauma (PTSD, depression, anxiety disorders), and impaired social functioning. A comprehensive multidisciplinary rehabilitation program (physical therapy, occupational therapy, pressure garments, psychological counseling) is essential for improving long-term prognosis. With advances in modern burn medicine, survival in 30–39% TBSA burns has steadily improved over the past 30 years, and survival of over 90% can now be expected in young, healthy patients.
Extensive burns reaching 30–39% of body surface area are largely preventable through multilayered prevention strategies at the individual, household, societal, and institutional levels. For home prevention, installing smoke detectors on every floor of the home and near each bedroom and sleeping area is most effective. Working smoke detectors are reported to reduce the risk of death in a fire by more than 60%. Detectors should be replaced every 10 years and checked monthly to confirm they work. Keeping a household fire extinguisher and knowing how to use it, not leaving a gas stove unattended while in use, and safe storage of flammable materials are also important.
Occupational prevention requires safety education for workers in hazardous industries (petrochemicals, welding, metal smelting, firefighting, etc.), mandatory wearing of personal protective equipment (flame-resistant clothing, face shields, insulated gloves), and establishment of workplace fire risk assessment and management systems. Compliance with electrical work safety rules and education in high-voltage isolation procedures are also essential for preventing electrical burns. Societal and institutional prevention includes applying flame-retardant standards to children's sleepwear, limiting the maximum temperature of water heaters (49°C or lower), mandating sprinkler systems in buildings, and fire evacuation drills in public places. Education to prevent smoking while under the influence of alcohol or drugs, and tailored fire safety support programs for older adults and people with disabilities, are also important means of prevention.
Baxter CR. Fluid volume and electrolyte changes in the early post-burn period. Clin Plast Surg. 1974;1(4):693–703. PMID: 4609676.
Pham TN, Cancio LC, Gibran NS; American Burn Association. American Burn Association practice guidelines burn shock resuscitation. J Burn Care Res. 2008;29(1):257–266. DOI: 10.1097/BCR.0b013e31815f3876. PMID: 18182930.
Osler T, Glance LG, Hosmer DW. Simplified estimates of the probability of death after burn injuries: extending and updating the baux score. J Trauma. 2010;68(3):690–697. DOI: 10.1097/TA.0b013e3181c453b3. PMID: 20220426.
Jeschke MG, van Baar ME, Choudhry MA, Chung KK, Gibran NS, Logsetty S. Burn injury. Nat Rev Dis Primers. 2020;6(1):11. DOI: 10.1038/s41572-020-0145-5. PMID: 32054846.
Herndon DN, Tompkins RG. Support of the metabolic response to burn injury. Lancet. 2004;363(9424):1895–1902. DOI: 10.1016/S0140-6736(04)16360-5. PMID: 15183630.
Greenhalgh DG. Management of burns. N Engl J Med. 2019;380(24):2349–2359. DOI: 10.1056/NEJMra1807442. PMID: 31189038.
Burke JF, Bondoc CC, Quinby WC. Primary burn excision and immediate grafting: a method shortening illness. J Trauma. 1974;14(5):389–395. DOI: 10.1097/00005373-197405000-00001. PMID: 4830631.
Brusselaers N, Monstrey S, Vogelaers D, Hoste E, Blot S. Severe burn injury in Europe: a systematic review of the incidence, etiology, morbidity, and mortality. Crit Care. 2010;14(5):R188. DOI: 10.1186/cc9300. PMID: 20958963.
Rousseau AF, Losser MR, Ichai C, Berger MM. ESPEN endorsed recommendations: nutritional therapy in major burns. Clin Nutr. 2013;32(4):497–502. DOI: 10.1016/j.clnu.2013.02.012. PMID: 23582468.
Hop MJ, Langenberg LC, Hiddingh J, et al. Reconstructive surgery after burns: a 10-year follow-up study. Burns. 2014;40(8):1544–1551. DOI: 10.1016/j.burns.2014.04.017. PMID: 24882540.